MT AXBN
Alternative Names: MT-AXBNLatest Information Update: 28 Apr 2022
Price :
$50 *
At a glance
- Originator Shaanxi Micot Technology Co
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Calcium metabolism disorders; Phosphorus metabolism disorders
Most Recent Events
- 28 Apr 2022 No recent reports of development identified for preclinical development in Calcium-metabolism-disorders in China (Parenteral)
- 28 Apr 2022 No recent reports of development identified for preclinical development in Phosphorus metabolism disorders in China (Parenteral)